糖尿病脚:病理生理学,免疫失调和新兴的治疗策略
John Dawi1, Kevin Tumanyan2, Kirakos Tomas2
1College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
Biomedicines
|May 28, 2025
概括
糖尿病足 (DFU) 是糖尿病的一个主要并发症,通常是由免疫系统功能障碍引起的. 针对免疫反应和利用再生医学的新疗法显示出治疗DFU和预防截肢的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病足 (DFU) 是糖尿病 (DM) 的严重并发症,导致严重的发病率,死亡率和医疗费用.
- 肺部功能障碍影响15-25%的糖尿病患者,并导致超过85%的非创伤性下肢截肢.
- 病理生理学涉及神经病变,血管疾病,炎症和再生障碍,免疫失调在慢性病症中发挥着关键作用.
研究的目的:
- 为了提供糖尿病足病变的最新合成.
- 强调免疫功能障碍在DFU慢性和治疗影响中的作用.
- 审查DFU管理的新兴治疗策略.
主要方法:
- 文献综述侧重于DFU的病原和免疫机制.
- 对慢性伤口免疫失调的最新研究进行分析.
- 检查新的治疗方法,包括免疫调节,再生医学和基于人工智能的技术.
主要成果:
- 免疫失调,包括巨细胞,T细胞和中性粒细胞功能障碍,维持了DFU的炎症状态.
- 由TNF-α,IL-1β和IL-6等细胞因子驱动的慢性炎症会损害诸如血管生成等伤口愈合过程.
- 新兴的疗法,如SGLT2抑制剂,生物制剂,干细胞和智能带,为改善DFU治疗提供了潜力.
结论:
- 免疫功能障碍是慢性糖尿病足病变的核心机制.
- 准免疫路径和采用再生策略是DFU治疗的有希望的途径.
- 个性化和先进的治疗方法对于加速愈合和降低DFU患者的截肢率至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
412
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
412
Peripheral Artery Disease IV: Nursing Management
48
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
48
Pathophysiology of Diabetes
1.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Psychoneuroimmunology: Diabetes and Cancer
68
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
68
Inflammatory Bowel Disease IV: Pharmacological Management
205
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
205


